🇺🇸 FDA
Patent

US 7115280

Particle formation methods and their products

granted A61KA61K9/00A61K9/14

Quick answer

US patent 7115280 (Particle formation methods and their products) held by Nektar Therapeutics UK, Ltd expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics UK, Ltd
Grant date
Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
60
CPC classes
A61K, A61K9/00, A61K9/14, A61K9/1652, A61K9/167